2023 annual financial data
Lexicon Pharmaceuticals 2023 Operating margin
Direct answer
Operating margin was -14,264.95%.
Operating income was -171,750,000 USD and net income was -177,119,000 USD.
Operating cash flow was -161,897,000 USD.
Get free Lexicon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,204,000 USD
- Operating income
- -171,750,000 USD
- Net income
- -177,119,000 USD
- Operating cash flow
- -161,897,000 USD